edoc

Items where contributor is "Hofmann, Daniela"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2022 | 2021

2022

Hofmann, D. and Smit, C. and Sayasone, S. and Pfister, M. and Keiser, J.. (2022) Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling. Clin Transl Sci, 15 (3). pp. 700-708.

Probst, A. and Hofmann, D. and Fedorova, O. S. and Mazeina, S. V. and Sokolova, T. S. and Golovach, E. and Keiser, J.. (2022) Pharmacokinetics of ascending doses of praziquantel in adults infected with Opisthorchis felineus in Western Siberia, Russian Federation. Antimicrobial agents and chemotherapy, 66 (10). e00526-22.

Smit, C. and Hofmann, D. and Sayasone, S. and Keiser, J. and Pfister, M.. (2022) Characterization of the population pharmacokinetics of moxidectin in adults infected with strongyloides stercoralis: support for a fixed-dose treatment regimen. Clinical pharmacokinetics, 61. pp. 123-132.

2021

Buchter, V. and Hofmann, D. and Häberli, C. and Keiser, J.. (2021) Characterization of moxidectin against; Strongyloides ratti:; in vitro; and; in vivo; activity and pharmacokinetics in the rat model. ACS Infect Dis, 7 (5). pp. 1069-1076.

Hofmann, D. and Sayasone, S. and Sengngam, K. and Chongvilay, B. and Hattendorf, J. and Keiser, J.. (2021) Efficacy and safety of ascending doses of moxidectin against; Strongyloides stercoralis; infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial. Lancet Infect Dis, 21 (8). pp. 1151-1160.

Hofmann, D. and Sayasone, S. and Keiser, J.. (2021) Development and validation of an LC-MS/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos. J Chromatogr B Analyt Technol Biomed Life Sci, 1166. p. 122556.

Patel, C. and Coulibaly, J. T. and Hofmann, D. and N'Gbesso, Y. and Hattendorf, J. and Keiser, J.. (2021) Efficacy and safety of albendazole in hookworm-infected preschool-aged children, school-aged children and adults in Côte d'Ivoire: a phase II randomized controlled dose-finding trial. Clinical infectious diseases, 73 (2). e494-e502.

Welsche, S. and Mrimi, E. C. and Keller, L. and Hürlimann, E. and Hofmann, D. and Hattendorf, J. and Ali, S. M. and Keiser, J.. (2021) Efficacy and safety of moxidectin and albendazole compared to ivermectin and albendazole co-administration in adolescents infected with Trichuris trichiura: a randomized controlled trial protocol. Gates Open Res, 5. p. 106.